Can Behçet's disease cause peripheral neuropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can Behçet's Disease Cause Neuropathy?

Yes, Behçet's disease can cause peripheral neuropathy, though it is a rare complication that occurs in approximately 10-15% of patients and is often subclinical.

Understanding Nervous System Involvement in Behçet's

Neurological involvement in Behçet's disease is recognized as a serious complication associated with poor prognosis 1. While the 2018 EULAR guidelines emphasize that nervous system involvement requires prompt treatment to prevent irreversible organ damage 1, the guidelines focus primarily on central nervous system (CNS) manifestations rather than peripheral neuropathy specifically.

Frequency and Clinical Presentation

The peripheral nervous system involvement in Behçet's is notably underrecognized:

  • Subclinical disease is common: Electrophysiological studies detect neuropathy in 14-15% of patients without any neurological symptoms 2, 3
  • Symptomatic cases are rare: Only about 5-8% of patients develop clinically evident peripheral neuropathy 3
  • Pattern of involvement: The neuropathy is typically an axonal sensorimotor polyneuropathy affecting distal nerves, with sensory nerves more prominently affected than motor nerves 2, 3, 4

Most Commonly Affected Nerves

When peripheral neuropathy occurs, the pattern is predictable:

  • Lower extremities predominate: Tibial and peroneal nerves are most frequently involved 5
  • Upper extremity involvement: Median and ulnar nerves can be affected 2
  • Autonomic dysfunction: Rarely, autonomic neuropathy may occur alongside sensorimotor involvement 4

Pathophysiology

The mechanism appears to be vasculitis of the vasa nervorum (small vessels supplying peripheral nerves) 5, 4, consistent with the systemic vasculitic nature of Behçet's disease. This distinguishes it from medication-related neuropathy (such as colchicine toxicity, which should be considered in the differential) 4.

Clinical Correlation

Important caveat: Disease duration matters. Patients with electrophysiologically detected neuropathy have significantly longer disease duration (8.8 years vs 5.3 years, p<0.05) 2, suggesting this is a late complication of chronic disease.

Diagnostic Approach

For patients with Behçet's disease:

  • Routine screening recommended: Conventional nerve conduction studies including F-wave responses should be performed even in asymptomatic patients to detect early neuropathy 2, 3
  • Look for: Paresthesias, weakness, reduced reflexes, and sensory deficits in distal extremities
  • Exclude other causes: Diabetes, vitamin deficiencies, medication toxicity (especially colchicine), and other systemic causes

Treatment Considerations

When peripheral neuropathy is confirmed in Behçet's:

  • Immunosuppression is key: Corticosteroids (prednisone) remain the cornerstone 5, 4
  • Refractory cases: TNF-α inhibitors, particularly golimumab, have shown benefit in treatment-resistant peripheral nervous system involvement 5
  • Combination therapy: Cyclophosphamide may be added for severe cases 4

The treatment approach mirrors that for other serious organ involvement in Behçet's, where rapid suppression of inflammation is essential to prevent permanent damage 1.

Clinical Pitfalls

  • Don't overlook subclinical disease: The absence of symptoms doesn't exclude neuropathy
  • Consider colchicine toxicity: If a patient on colchicine develops neuropathy, distinguish between disease-related and drug-induced causes
  • Mixed presentations exist: Peripheral neuropathy can coexist with CNS involvement in neuro-Behçet's 6, 7

References

Related Questions

How should neuro‑Behçet disease presenting with new focal neurologic deficits, severe headache, meningeal signs, or psychiatric changes be diagnosed and treated?
What is the typical life span and quality of life for someone with Behçet's disease (BD) versus neuro-Behçet's disease?
What are the current guidelines for clinical breast examination and breast cancer screening in women?
In a 75-year-old woman with known hypertension and a prior ischemic cerebrovascular accident who presents to the emergency department with altered consciousness and seizures, what is the appropriate emergency management?
In a patient with chronic constipation and abdominal pain refractory to multiple medications including polyethylene glycol 3350 (Miralax) and docusate sodium (stool softener), what laboratory tests should be ordered?
In a patient with hyperkalaemia due to suspected type 4 renal tubular acidosis, how should I treat the acute hyperkalaemia, should I obtain plasma aldosterone and renin levels, and when is fludrocortisone indicated?
Which specialist should manage a patient with asymptomatic primary hyperparathyroidism?
What factors can cause an elevated serum lithium level in a patient receiving a low dose of lithium?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.